UiPath Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Benzinga Earnings
09/03

UiPath, Inc. (NYSE:PATH) will release its second earnings report after the closing bell on Thursday, Sept. 3.

Analysts expect the New York-based company to report quarterly earnings of 15 cents per share, versus 15 cents per share in the year-ago period. The consensus estimate for UiPath’s quarterly revenue is $397.85 million. It reported $361.73 million last year, according to Benzinga Pro.

On May 29, UiPath reported mixed financial results for the first quarter.

UiPath shares fell 0.8% to close at $17.99 on Wednesday.

Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.

Let’s have a look at how Benzinga’s most-accurate analysts have rated the company in the recent period.

  • UBS analyst Radi Sultan maintained a Neutral rating and boosted the price target from $12 to $19 on Aug. 31, 2026. This analyst has an accuracy rate of 69%.
  • RBC Capital analyst Matthew Hedberg maintained a Sector Perform rating and increased the price target from $12 to $15 on Aug. 14, 2026. This analyst has an accuracy rate of 74%.
  • BMO Capital analyst Keith Bachman maintained a Market Perform rating and cut the price target from $14 to $13 on June 1, 2026. This analyst has an accuracy rate of 77%.
  • DA Davidson analyst Lucky Schreiner maintained a Neutral rating and lowered the price target from $13 to $12 on May 29, 2026. This analyst has an accuracy rate of 50%.
  • B of A Securities analyst Brad Sills maintained an Underperform rating and boosted the price target from $12 to $13 on May 29, 2026. This analyst has an accuracy rate of 60%.

Considering buying PATH stock? Here’s what analysts think:

Photo via Shutterstock

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10